Deep Genomics Stock
Deep Genomics is a biopharmaceutical company specializing in AI-powered drug discovery for genetic diseases. Its proprietary AI Workbench platform decodes the complexities of Ribonucleic Acid (RNA) biology to identify novel therapeutic targets and design RNA-based therapies, enabling the development of treatments for currently untreatable conditions.
Founded: 2014
For more Deep Genomics stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Brian O'Callaghan, M.B.A. Chief Executive Officer |
| Brendan Frey, Ph.D. Founder and Chief Innovation Officer |
| David Johnston, M.B.A. Chief Financial Officer |
| Matt Cahill J.D., M.B.A., Ph.D. Chief Strategy Officer |
| Clive Bertram Chief Business Officer |
| Tom Masterson, M.B.A. Chief Operating Officer |
| Greg Hoffman, Ph.D. Chief Scientific Officer |
| Radu Dobrin, Ph.D. Chief Technology Officer |
